Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | EPHA4 | P54764 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.33 |
| ▸ | KMO | O15229 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2166315 | 0.86 | ALDH1A1 (0.49) | HRH4CYP2C19ALDH1A1KEAP1NFE2L2 | |
| SCHEMBL4878194 | 0.84 | ALDH1A1 (0.47) | HRH4CYP2C19ALDH1A1KEAP1NFE2L2 | |
| SCHEMBL4876866 | 0.83 | ALDH1A1 (0.46) | HRH4CYP2C19ALDH1A1KEAP1NFE2L2 | |
| SCHEMBL4877590 | 0.83 | CYP2C19 (0.51) | CYP2C19ALDH1A1KEAP1NFE2L2CYP3A4 | |
| SCHEMBL4875265 | 0.81 | CYP2C19 (0.43) | HRH4CYP2C19ALDH1A1KEAP1NFE2L2 | |
| SCHEMBL3135449 | 0.79 | CYP2C19 (0.47) | CYP2C19ALDH1A1KEAP1NFE2L2CYP3A4 | |
| SCHEMBL3131985 | 0.79 | CYP2C19 (0.47) | CYP2C19ALDH1A1KEAP1NFE2L2CYP3A4 | |
| SCHEMBL3128908 | 0.79 | CYP2C19 (0.47) | CYP2C19ALDH1A1KEAP1NFE2L2CYP3A4 | |
| SCHEMBL3137466 | 0.77 | CYP2C19 (0.44) | CYP2C19ALDH1A1KEAP1NFE2L2CYP3A4 | |
| SCHEMBL4878269 | 0.76 | HRH4 (0.55) | HRH4NPY5REPHA4PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8735411-B2 | Macrocyclic benzofused pyrimidine derivatives | ABBVIE INC. (US) | 2014-05-27 | — | — | US | disclosed |
| US-20080188452-A1 | Macrocyclic Benzofused Pyrimidine Derivatives | ABBVIE INC. | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188452-A1 | Macrocyclic Benzofused Pyrimidine Derivatives | DPYD, TYMS, UMPS | HRH4 3013/4885CYP2C19 685/4885NPY5R 4096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.